• Calendar Subscription
• Bookmark and Share
• Contact Us
• E-mail a Colleague

3^rd Melanoma Pathology Symposium of the International Melanoma Pathology Working Group

Program now available

The 3rd Melanoma Pathology Symposium is a full day symposium will be accessible to joint registrants of the Interdisciplinary Melanoma / Skin Cancer Centres and the Society for Melanoma Research conferences. It will highlight important contemporary issues in melanoma pathology, clinical care and research and present state of the art reviews.

Invited Speakers

We are pleased to announce that the following invited speakers will be presenting at Melanoma 2010:

• Alan Spatz (Canada) - Biography
  
  Dr. Alan Spatz is Director of the Pathology Department at the Jewish General Hospital, and Professor of Pathology and Oncology at McGill University. He holds a Canada Research Chair in Molecular Pathology.
  
  Dr. Spatz is Co-Chairman of the National Cancer Institute of Canada Melanoma committee. Dr. Spatz served as Chairman of the EORTC Melanoma group, and as President of the French division of the International Academy of Pathology. He currently serves as a board member of several international professional organizations and on editorial boards and international strategic committees.
  
  Dr. Spatz is also Program Director of the McGill Integrated Cancer Research Training Program.
  
  Dr. Spatz leads an international research group on cutaneous melanoma. His current research involves the X chromosome role in metastatic potential and key factors associated with cancer progression. He has authored more than 150 original scientific papers, reports, review articles, and books.
• Alistair Cochran (United States of America) - Biography
  
  Alistair J Cochran MD is Distinguished Professor of Pathology and Surgery at UCLA, Los Angeles. Dr Cochran studied medicine at the University of Glasgow undertook residency training in pathology at the Western Infirmary Glasgow and a post-doctoral fellowship in tumor immunology at the Karolinska Institute, Stockholm. He was Reader at the University of Glasgow, before recruitment to UCLA. His research has focused on the pathobiology of melanoma: classification, assessment of prognosis, immunology and immunotherapy and molecular and genetic mechanisms of metastasis. The Cochran team developed S-100 protein as the first immuno-marker for melanocytic tumors and with Dr Donald Morton developed lymphatic mapping and sentinel node biopsy and organized international trials of these techniques He lists more than 380 medical and scientific publications.
• Boris Bastian (United States of America)
• Chris Shea (United States of America)
• Chris Allan - Biography
  
  Dr Allan attained his primary medical degree with the University of Queensland in 1996 and his Fellowship in General Surgery with the Royal Australasian College of Surgeons in 2006. He completed two years of subspecialty training in Breast and Endocrine Surgery at the Mater Adult Hospital in Brisbane followed by Melanoma and Soft Tissue Sarcoma Surgery at the Royal Marsden Hospital in London. Through the University of Queensland, he attained a Master of Philosophy research degree in breast cancer vaccine development and holds an academic appointment as a Senior Lecturer in Surgery. Dr Allan is a VMO Surgeon at the Mater Adult and Private Hospitals and the Princess Alexandra Hospital Melanoma Unit in Brisbane.
• David Elder (United States of America)
• Gilles Landman (Brasil) - Biography
  
  Biography:
  Gilles Landman, M.D., PhD.
  Dermatopathologist
  Scientific Director of the Brazilian Melanoma Group.
  
  Past president – Brazilian Melanoma Group – 2004 to 2005 and 2005 to 2007.
  Past president – Brazilian Society of Dermatopathology
  Pathologist at the Hospital AC Camargo – 1996 to 2010
  
  Research interest:
  Pathology, immunohistochemistry and molecular biology of melanoma
  Dermatopathology
  
  Ongoing projects:
  Familial melanoma – Joint project with Latin America GenoMEL study group
  Acral Melanoma – Molecular and immunohistochemical evaluation in paraffin embedded tissue.
  Apoptosis in melanoma
  MAPK in melanoma
• Klaus Busam (United States of America) - Biography
  Klaus J Busam, M.D., is a graduate of the Albert-Ludwig's Universitaet in Freiburg, Germany. After a postdoctoral fellowship at the National Cancer Institute in Bethesda, MD, USA, he completed a residency in Anatomic Pathology at Brigham and Women's Hospital and subsequently a fellowship at the Harvard Dermatopathology program in Boston, MA. Thereafter, he joined the Department of Pathology of Memorial Sloan-Kettering Cancer Center. He is currently Professor of Pathology and Laboratory Medicine at the Weill Medical College of Cornell University and Director of the combined New York Presbyterian - Cornell and MSKCC Dermatopathology Fellowship Training Program. His research focuses on improvements in the diagnosis and prognosis of skin tumors, especially melanocytic proliferations.
• Lorenzo Cerroni (Austria) - Biography
  
  Dr. Cerroni was born in Rome (Italy) in 1959. Since 1994 he is Associate Professor of Dermatology, and since 2005 Director of the Research Unit Dermatopathology at the Medical University of Graz, Austria. He is past-President of the International Society of Dermatopathology and of the Austrian Society of Dermatopathology, and Associate Editor of Dermatology, the American Journal of Dermatopathology and the Journal of the European Academy of Dermatology and Venereology. His main area of interest are cutaneous lymphomas and melanocytic tumors. Dr. Cerroni is author of 8 books and >400 scientific manuscripts, and gave >400 lectures as invited speaker including the Geoffrey Hunter Oration, the Elson B. Helwig Memorial Lecture, and the David Weedon Lecture.
• Lori Lowe (United States of America) - Biography
  
  Dr. Lori Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981. She received her M.D. degree and residency training in dermatology from the University of Texas Medical School at Houston. She then completed dermatopathology fellowship training at the University of Colorado School of Medicine. Dr. Lowe is board certified in both Dermatology and Dermatopathology.
  
  Dr. Lowe was Director of Dermatopathology at Henry Ford Hospital, Detroit, Michigan from 1991-1996. In 1996, she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School as Assistant Professor. She was promoted to Associate Professor in 1998 and to Professor in 2004. She has served as the Director of Dermatopathology since 1997. Dr. Lowe is a member of the University of Michigan Multidisciplinary Melanoma Program. She has authored or coauthored greater than 90 manuscripts in peer-reviewed journals.
• Lyn Duncan (United States of America) - Biography
  Dr. Duncan is Chief of the Massachusetts General Hospital Dermatopathology Unit and an expert dermatopathologist and melanoma scientist. After completing medical school and residency in Anatomic Pathology at Washington University in St. Louis she received her training in Dermatopathology at Harvard. She joined the faculty at the MGH in 1991, served as the Director of the Harvard Dermatopathology Training Program from 1993-2003 and is currently the MGH Institutional PI for the Harvard Skin SPORE. Dr. Duncan's research in cutaneous lymphoma and melanoma has led to revised classifications, an understanding of melanoma heterogeneity and the identification of novel prognostic factors.
• Martin Cook (United Kingdom)
• Marty Mihm (United States of America) - Biography
  
  
  
  
  
  
  
  
  
  
  
  
• Michael Piepkorn (United States of America) - Biography
  Dr. Michael Piepkorn is a Clinical Professor of Medicine in the Division of Dermatology at the University of Washington, Seattle, WA. He received post graduate medical training in the fields of anatomical pathology and dermatology, with a specialized interest in dermatopathology, particularly as it pertains to the pathology of melanocytic proliferations. He has been involved in basic research in melanoma and is currently involved in aspects of clinical research of that disease spectrum.
  
  
  
  
• Raymond Barnhill (France)
• Richard Scolyer (Australia) - Biography
  
  Richard Scolyer is a medical graduate of the University of Tasmania (BMedSci, MBBS). After completing clinical training in Australia and overseas, he undertook pathology training at the Canberra Hospital and at the Royal Prince Alfred Hospital leading to Fellowship of the Royal College of Pathologists of Australasia.
  
  Richard has a broad range of interests in surgical pathology and cytopathology with special interests in melanocytic pathology and soft tissue pathology. He is also interested in teaching, education and translational research (particularly in the field of melanoma). In 2006, Richard was awarded the degree of Doctor of Medicine by the University of Sydney for his thesis of publications on melanocytic pathology. He received a NSW Premier's Award for Outstanding Cancer Research in 2009.  Richard is also Clinical Professor at the University of Sydney, an editorial board member of the American Journal of Surgical Pathology and Associate Editor of Pathology.
• Stan McCarthy (Australia) - Biography
  Prof Stan McCarthy, a graduate of the University of Sydney in 1963, is a Senior Staff Specialist and consultant histopathologist at Royal Prince Alfred Hospital in Sydney. His general pathology training was based at Sydney Hospital and he maintains a keen interest in its now divided Kanematsu Pathology Museum. His special areas are melanocytic lesions (servicing the Sydney Melanoma Unit since its inception), skin tumours and lesions of bone and soft tissue. Past positions have included Registrar of the Board of Censors (RCPA 1974-7) and Curator of the NSW Bone Tumour Registry. He was awarded an Order of Australia (AO) in 1996 for services to medicine particularly cancer pathology. He received the International Academy of Pathology (Australasian Division) Distinguished Pathologist Medal for 2009 and the RCPA Distinguished Fellow Award in 2010.
• Victor Tron - Biography
  Dr. Tron is Professor and Head of the Department of Pathology and Molecular Medicine at Queen’s University.  He is also Pathologist-In-Chief at Kingston General Hospital.  Prior to this, Dr. Tron was Professor and Chairman, and Regional Medical Laboratory Director at the University of Alberta.  A graduate of the University of Alberta, Dr Tron completed his specialty training at UBC and his fellowship at Harvard University. 
  
  His CIHR funded research investigates molecular aspects of melanoma.  Recently, his group demonstrated the effectiveness of combinational therapy for melanoma using RNAi and small molecular inhibitors.  A further focus is discovery and experimental validation of microRNAs involved in melanoma progression.  Clinically, Dr. Tron serves as consultant Dermatopathologist at Kingston General Hospital and surrounding institutions.